Syndax Pharmaceuticals SNDX
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2024Q3 | 19.25 | 366 | -21.01 | -84 | -18.64 | 426 |
| 2024Q2 | 20.53 | 434 | -14.70 | -68 | -13.35 | 477 |
| 2024Q1 | 23.80 | 492 | -13.84 | -72 | -12.53 | 543 |
| 2023Q4 | 21.61 | 554 | -15.87 | -72 | -14.32 | 613 |
| 2023Q3 | 14.52 | 359 | -13.47 | -51 | -12.32 | 399 |
| 2023Q2 | 20.93 | 400 | -10.68 | -45 | -10.01 | 431 |
| 2023Q1 | 21.12 | 436 | -9.11 | -41 | -8.59 | 460 |
| 2022Q4 | 25.45 | 467 | -9.73 | -39 | -9.15 | 497 |
| 2022Q3 | 24.03 | 338 | -10.11 | -35 | -9.24 | 360 |
| 2022Q2 | 19.24 | 362 | -10.20 | -38 | -9.07 | 406 |
| 2022Q1 | 17.38 | 375 | -9.50 | -37 | -8.53 | 422 |
| 2021Q4 | 21.89 | 408 | 31.68 | 96 | 27.92 | 450 |
| 2021Q3 | 19.11 | 199 | -9.98 | -21 | -8.21 | 240 |
| 2021Q2 | 17.17 | 215 | -10.35 | -23 | -8.44 | 263 |
| 2021Q1 | 22.36 | 228 | -11.54 | -28 | -9.55 | 280 |
| 2020Q4 | 22.24 | 252 | -10.63 | -20 | -8.51 | 301 |
| 2020Q3 | 14.76 | 132 | -14.62 | -20 | -10.99 | 179 |
| 2020Q2 | 14.82 | 148 | -16.96 | -17 | -11.46 | 193 |
| 2020Q1 | 10.97 | 54 | -35.80 | -15 | -18.06 | 105 |
| 2019Q4 | 8.78 | 32 | -37.02 | -14 | -20.01 | 64 |